HETEROCYCLES
An International Journal for Reviews and Communications in Heterocyclic ChemistryWeb Edition ISSN: 1881-0942
Published online by The Japan Institute of Heterocyclic Chemistry
e-Journal
Full Text HTML
Received, 29th September, 2008, Accepted, 27th October, 2008, Published online, 31st October, 2008.
DOI: 10.3987/COM-08-S(D)41
■ Naucleamide F, a New Monoterpene Indole Alkaloid from Nauclea latifolia
Yuka Kakuguchi, Haruaki Ishiyama, Takaaki Kubota, and Jun'ichi Kobayashi*
Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita 12 Nishi 6, Kita-ku, Sapporo, Hokkaido 060-0812, Japan
Abstract
A new monoterpene indole alkaloid, naucleamide F (1), has been isolated from the bark and wood of Nauclea latifolia, and the structure and stereochemistry were elucidated on the basis of the spectral data. Naucleamide F (1) is a new monoterpene indole alkaloid consisting of a tetrahydro-β-carboline ring fused to a pyridone ring, and a 1,3,5-trioxepane ring fused to a dihydropyran ring and a glucose unit.INTRODUCTION
A number of monoterpene indole alkaloids with biological activities have been isolated from Nauclea species (Rubiaceae).1-4 In our search for bioactive metabolites from medicinal plants, we previously isolated new monoterpene indole alkaloids, naucleamides A~E5, from the bark and wood of Nauclea latifolia. Further investigation of extracts from this plant resulted in the isolation of a new monoterpene indole alkaloid, naucleamide F (1), consisting of a heptacyclic ring system including a tetrahydro-β-carboline ring fused to a pyridone ring, and a 1,3,5-trioxepane ring fused to a dihydropyran ring and a glucose unit. Here we describe the isolation and structure elucidation of 1.
RESULTS AND DISCUSSION
The bark and wood of Nauclea latifolia were extracted with MeOH. The MeOH extracts were partitioned between hexane and 90% aqueous MeOH, and then the MeOH layer was subsequently extracted with n-BuOH. The n-BuOH-soluble materials were purified by a silica gel column (CHCl3-MeOH, 1:0 → 85:15) followed by a C18 column (MeOH-H2O, 60:40) and C18 HPLC (CH3CN-H2O, 40:60) to afford naucleamide F (1, 0.0003%) together with known related monoterpene indole alkaloids, angustoline6 (2, 0.0004%), compound 37 (0.0004%), and compound 47 (0.0003%).
The molecular formula, C26H26N2O8, of naucleamide F (1) was established by HR-ESI-MS [m/z 517.1592 (M+Na)+, Δ +0.5 mmu]. IR absorptions implied the presence of hydroxy (3443 cm-1) and amide carbonyl (1645 cm-1) functionalities. 1H and 13C NMR data (Table 1) and the HMQC spectrum suggested that 1 possessed one carbonyl, seven sp2 quaternary carbons, six sp2 methines, one sp2 methylene, three sp3 methylenes, one sp3 methine, four sp3 oxymethines, and three acetal methines. Among them, one oxymethylene carbon (δC 63.3), five oxymethine carbons (δC 82.2, 79.8, 77.0, 71.4, and 63.3), and one acetal methine carbon (δC 99.8) were ascribed to a glucopyranose unit (C-1'~C-6').8 The 1H-1H COSY and TOCSY spectra of 1 revealed connectivities of four partial structures, C-5 to C-6, C-9 to C-12, C-18 to C-20, and C-1' to C-6'. HMBC cross-peaks of H-5 to C-7 and C-22, H-9 to C-7 and C-13, H-12 to C-8, H-14 to C-2 and C-3, and H-20 to C-14 and C-15 indicated the presence of a tetrahydro-β-carboline ring (N-1, C-2, C-3, N-4, and C-5~C-13) fused to a pyridone ring (C-3, N-4, C-14~C-16, and C-22) at C-3 and N-4, which was connected to an sp3 methine (C-20). The presence of a 1,3,5-trioxepane ring (C-17, O-17, C-21, O-1', C-1', C-2', and O-2') fused to a dihydropyran ring (C-15~C-17, C-20, C-21, and O-17) at C-17 and C-21, and a glucose unit (C-1'~C-6' and O-5') at C-1' and C-2' was elucidated by HMBC correlations of H-17 to C-16 and C-2’, H-21 to C-15 and C-17, and NOESY correlations for H-20 to H-21 and H-21 to H-1'.
The relative stereochemistry of 1 was deduced from NOESY correlations of H-17 to H-19, H-20 to H-21, H-1' to H-21, H-3', and H-5', and a J-value for H-20/H-21 (~0 Hz) as shown in Figure 2.
Since the sugar moiety was elucidated to be D-glucopyranose by chiral HPLC analysis of O-benzoyl derivatives of the methanolysis products of naucleamide F (1),9 the absolute stereochemistry of naucleamide F (1) was assigned as shown in Figure 2.
The absolute stereochemistries of known related monoterpene indole alkaloids 2~4, whose stereochemistries remains unsolved,6,7 were elucidated as describe below. The absolute configurations at C-3 of 3 and 4 were assigned as both R on the basis of the negative Cotton effects at 279 nm (Δε -0.29) and 253 nm (Δε -0.72), respectively,10 while the absolute configurations at C-19 of 2 ~ 4 were elucidated to be S, S, and R on the based of the Δδ values obtained for (S)- and (R)-MTPA esters of 2 ~ 4, respectively 11 (Figure 3).
Naucleamide F (1) is a new monoterpene indole alkaloid consisting of a tetrahydro-β-carboline ring fused to a pyridone ring, and a 1,3,5-trioxepane ring fused to a dihydropyran ring and a glucose unit. Naucleamide F (1) is a rare monoterpene indole alkaloid possessin a glucose unit connected to terpenoid unit via two ether bonds, though an iridoid having a similar unit has been reported from the bark of Eucommia ulmoides.8
EXPERIMENTAL
General Experimental Procedures
Optical rotation was recorded on a JASCO P-1030 polarimeter. IR and UV spectra were recorded on a JASCO FT/IR-5300 spectrophotometers and Shimadzu UV-1600PC, respectively. 1H, 13C and 2D NMR spectra were measured on a JEOL JMN-EX400, a JEOL ECA500, and a Bruker AMX-600 spectrometers. The 3.35 and 49.8 ppm resonances of residual CD3OD were used as internal references for 1H and 13C NMR spectra, respectively. ESI mass spectra were measured on a JEOL JMS-700TZ spectrometer.
Extraction and Isolation
The bark and wood (300 g) of Nauclea latifolia were extracted with MeOH (1.5 L), and the extracts were partitioned between hexane (200 mL x 3) and 90% aqueous MeOH (200 mL). The MeOH layer was partitioned between n-BuOH (200 mL x 3) and H2O (200 mL). The n-BuOH-soluble portions (3.4 g) were subjected to a silica gel column chromatography (CHCl3-MeOH, 1:0 → 85:15) to afford fraction a (583 mg). Fraction a was separated by a C18 column chromatography (MeOH-H2O, 60:40) followed by C18 HPLC (Capcell Pak RP-18, Shiseido Co. Ltd, 10 x 250 mm; flow rate 2.5 mL/min; UV detection at 210 nm; eluent CH3CN/H2O, 40:60) to afford naucleamide F (1, 0.85 mg, tR 17 min), angustoline (2, 1.3 mg, tR 42 min), compound 3 (3, 1.2 mg, tR 30 min), and compound 4 (4, 0.69 mg, tR 28 min).
Naucleamide F (1): pale yellow amorphous solid; [α]D 25 +44 (c 0.21, MeOH); UV (MeOH) λmax 210 nm (log ε 3.97), 261 (3.44), 289 (3.28), 301 (3.18), and 354 (3.57); IR (KBr) cm-1: 3443, 2920, 1645; 1H- and 13C-NMR (Table 1); ESI-MS m/z 517 (M+Na)+; HR-ESI-MS m/z 517.1592 (M+Na)+ (calcd. for C26H26N2O8Na, 517.1587).
Stereochemical assignment of the sugar unit in naucleamide F (1).
Naucleamide F (1, 0.1 mg) was treated with 3% HCl/MeOH (300 μL) at 110 oC for 1h. After the solvent was removed by nitrogen stream, to the residue was added EtOAc (100 μL), and the EtOAc solution was extracted with H2O (100 μL x 3). The aqueous fraction evaporated in vacuo was treated pyridine (100 μL), triethylamine (15 μL), and benzoyl chloride (15 μL), at rt for 21 h. After addition of MeOH (100 μL), the reaction mixture was extracted with n-hexane (100 μL x 3). The n-hexane-soluble fraction was evaporated in vacuo to afford 1-O-methyl-2,3,4,6-tetra-O-benzoyl derivative of the sugar units of 1. Authentic D- and L-glucose were treated with benzoyl chloride as described above to afford 1-O-methyl-2,3,4,6-tetra-O-benzoyl derivatives of D- and L-glucose, respectively. The 1-O-methyl-2,3,4,6-tetra-O-benzoyl derivatives were subjected to chiral HPLC analyses using Chiralpak OD-R (Daicel Chemical Industry, Ltd., 4.6 x 250 mm; flow rate 0.5 mL/min; UV detection at 254 nm; eluent MeOH/H2O, 95:5). The retention time of 1-O-methyl-2,3,4,6-tetra-O-benzoyl derivative of methanolysis product of 1 was found to be 18.6 min, while the retention times of authentic 1-O-methyl-2,3,4,6-tetra-O-benzoyl-α-D-glucopyranose and 1-O-methyl-2,3,4,6-tetra-O-benzoyl-α-L- glucopyranose were found to be 18.6 and 20.2 min, respectively.
Preparation of (S)- and (R)-MTPA esters of compounds 2~4.
To a solution of 2 (0.1 mg) in CH2Cl2 (100 μL) were added (R)-MTPACl (0.68 mg), triethylamine (2.0 μl), and N,N-demethyl-aminopyridine (4.1 mg). The mixture was allowed to stand at rt for 3 h. After evapolation of the solvent, the residue was applied to a silica gel column to give the (S)-MTPA ester of 1. The (R)-MTPA ester of 2 and (S)- and (R)-MTPA esters of 3 and 4 were prepared according to the same procedure as described above.
(S)-MTPA ester of 2: 1H NMR (CD3OD) δ9.40 (H-17), 8.67 (H-21), 6.69 (H-19), 1.82 (H-18); ESIMS m/z 548 (M+H)+.
(R)-MTPA ester of 2: 1H NMR (CD3OD) δ9.38 (H-17), 8.64 (H-21), 6.40 (H-19), 1.94 (H-18); ESIMS m/z 548 (M+H)+.
(S)-MTPA ester of 3: 1H NMR (CD3OD) δ9.40 (H-17), 8.67 (H-21), 6.69 (H-19), 1.51 (H-18); ESIMS m/z 546 (M+H)+.
(R)-MTPA ester of 3: 1H NMR (CD3OD) δ9.11 (H-17), 8.53 (H-21), 6.44 (H-19), 1.78 (H-18); ESIMS m/z 546 (M+H)+.
(S)-MTPA ester of 4: 1H NMR (CD3OD) δ9.37 (H-17), 8.53 (H-21), 6.69 (H-19), 2.20 (H-18); ESIMS m/z 546 (M+H)+.
(R)-MTPA ester of 4: 1H NMR (CD3OD) δ9.40 (H-17), 8.69 (H-21), 6.39 (H-19), 1.80 (H-18); ESIMS m/z 546 (M+H)+.
ACKNOWLEDGMENTS
We thank Ms. S. Oka (Center for Instrumental Analysis, Hokkaido University) for measurements of ESIMS. This work was partly supported by a grant from a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
References
1. F. Hotellier, P. Delaveau, and J. L. Pousset, Phytochemistry, 1975, 14, 1407. CrossRef
2. F. Hotellier, P. Delaveau, and J. L. Pousset, Planta Med., 1979, 35, 242. CrossRef
3. Z. Zhang, H. N. ElSohly, M. R. Jacob, D. S. Pasco, L. A. Walker, and A. M. Clark, J. Nat. Prod., 2001, 64, 1001. CrossRef
4. H. Takayama, O. Ohmori, M. Sakai, M. Funahashi, M. Kitajima, D. Santiarworn, B. Liawruangrath, and N. Aimi, Heterocycles, 1998, 49, 40. CrossRef
5. H. Shigemori, T. Kagata, H. Ishiyama, F. Morah, A. Ohsaki, and J. Kobayashi, Chem. Pharm. Bull., 2003, 51, 58. CrossRef
6. F. Hotellier, P. Delaveau, and J. L. Pousset, Phytochemistry, 1975, 14, 1407. CrossRef
7. C. A. J. Erdelmeier, U. Regenass, T. Rali, and O. Sticher, Planta Med., 1992, 58, 43. CrossRef
8. C. Takamura, T. Hirata, T. Ueda, M. Ono, H. Miyashita, T. Ikeda, and T. Nohara, J. Nat. Prod., 2007, 70, 1312. CrossRef
9. J. Kobayashi, T. Kubota, M. Takahashi, M. Ishibashi, M. Tsuda, and H. Naoki, J. Org. Chem., 1999, 64, 1478. CrossRef
10. C. M. Lee, W. F, Trager, and A. H. Beckett, Tetrahedron, 1967, 23, 375. CrossRef
11. I. Ohtani, T. Kusumi, Y. Kashman, and H. Kakisawa, J. Am. Chem. Soc., 1991, 113, 4092. CrossRef